Zhongjin Irradiation Incorporated Company

SZSE:300962 Stock Report

Market Cap: CN¥4.7b

Zhongjin Irradiation Past Earnings Performance

Past criteria checks 2/6

Zhongjin Irradiation has been growing earnings at an average annual rate of 11.3%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 7.3% per year. Zhongjin Irradiation's return on equity is 11.5%, and it has net margins of 30.1%.

Key information

11.3%

Earnings growth rate

5.3%

EPS growth rate

Healthcare Industry Growth7.0%
Revenue growth rate7.3%
Return on equity11.5%
Net Margin30.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Earnings Troubles May Signal Larger Issues for Zhongjin Irradiation (SZSE:300962) Shareholders

Jul 22
Earnings Troubles May Signal Larger Issues for Zhongjin Irradiation (SZSE:300962) Shareholders

Recent updates

Zhongjin Irradiation Incorporated Company's (SZSE:300962) Price Is Out Of Tune With Earnings

Sep 28
Zhongjin Irradiation Incorporated Company's (SZSE:300962) Price Is Out Of Tune With Earnings

Earnings Troubles May Signal Larger Issues for Zhongjin Irradiation (SZSE:300962) Shareholders

Jul 22
Earnings Troubles May Signal Larger Issues for Zhongjin Irradiation (SZSE:300962) Shareholders

Zhongjin Irradiation (SZSE:300962) Is Paying Out Less In Dividends Than Last Year

Jun 14
Zhongjin Irradiation (SZSE:300962) Is Paying Out Less In Dividends Than Last Year

Revenue & Expenses Breakdown

How Zhongjin Irradiation makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300962 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 243581077227
30 Jun 243541096927
31 Mar 243481096926
31 Dec 233451086826
30 Sep 233441106527
30 Jun 233431126426
31 Mar 233391096326
01 Jan 233371086226
30 Sep 223321006124
30 Jun 22325946223
31 Mar 22319936122
01 Jan 22309876121
30 Sep 21304964719
30 Jun 21291904518
31 Mar 21282824618
31 Dec 20256624518
31 Dec 19253585216
31 Dec 18244534815
31 Dec 17214394911
31 Dec 1519030490
31 Dec 1415620450
31 Dec 1313427370

Quality Earnings: 300962 has high quality earnings.

Growing Profit Margin: 300962's current net profit margins (30.1%) are lower than last year (32.1%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300962's earnings have grown by 11.3% per year over the past 5 years.

Accelerating Growth: 300962's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 300962 had negative earnings growth (-2.6%) over the past year, making it difficult to compare to the Healthcare industry average (-5.7%).


Return on Equity

High ROE: 300962's Return on Equity (11.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 22:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhongjin Irradiation Incorporated Company is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution